Mezzion Pharma Co 140410
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 140410 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- KRW 38,250.00
- Day Range
- KRW 38,350.00–39,550.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 38,550.00 / KRW 38,750.00
- Market Cap
- KRW 1.14 Tril
- Volume/Avg
- 69,560 / 197,455
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 33.69
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Mezzion Pharma Co is a South Korea based drug manufacturer company. It develops and manufactures pharmaceutical products for erectile dysfunction and benign prostatic hyperplasia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 46
- Website
- http://www.mezzion.co.kr
Comparables
Valuation
|
Metric
|
140410
|
293480
|
016580
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 10.25 | 7.11 |
Price/Book Value | 21.73 | 0.83 | 0.59 |
Price/Sales | 33.69 | 1.03 | 0.92 |
Price/Cash Flow | — | 7.57 | 5.43 |
Price/Earnings
140410
293480
016580
Financial Strength
|
Metric
|
140410
|
293480
|
016580
|
|---|---|---|---|
Quick Ratio | 2.17 | 0.93 | 3.93 |
Current Ratio | 2.51 | 1.82 | 5.30 |
Interest Coverage | −43.24 | — | 1,345.19 |
Quick Ratio
140410
293480
016580
Profitability
|
Metric
|
140410
|
293480
|
016580
|
|---|---|---|---|
Return on Assets (Normalized) | −17.65% | 6.72% | 7.92% |
Return on Equity (Normalized) | −33.91% | 8.59% | 8.87% |
Return on Invested Capital (Normalized) | −28.13% | 7.47% | 7.89% |
Return on Assets
140410
293480
016580
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Zlzkrhclvn | Ppdd | $697.4 Bil | |
JNJ
| Johnson & Johnson | Npvgkbwnh | Bbnq | $353.8 Bil | |
MRK
| Merck & Co Inc | Crhrglbm | Jnr | $332.3 Bil | |
ABBV
| AbbVie Inc | Vgzxlvw | Cqyb | $282.6 Bil | |
AZN
| AstraZeneca PLC ADR | Tjbcmnsy | Sfyqs | $232.3 Bil | |
NVS
| Novartis AG ADR | Qpgjhxccq | Lrrf | $200.1 Bil | |
RHHBY
| Roche Holding AG ADR | Rzwkpkrcff | Vcfvd | $195.3 Bil | |
AMGN
| Amgen Inc | Zzwsjbpryy | Zgg | $144.5 Bil | |
PFE
| Pfizer Inc | Xxtlqlnjk | Dzvv | $143.8 Bil | |
SNY
| Sanofi SA ADR | Rzmrqhct | Lvzb | $122.2 Bil |